Gilead strikes $35m AI drug discovery deal with Genesis
FierceBiotech - 10-Sep-2024The biotech’s advanced AI platform aims to unlock new treatments for challenging drug targets
Join the club for FREE to access the whole archive and other member benefits.
Writer for Fierce Pharma
Zoey Becker is a staff writer at Fierce Pharma, having joined the team in 2022 following an internship at the Cincinnati Herald. She holds a degree in journalism and sociology from Miami University. Zoey currently lives in Chicago with her two goldfish.
Visit website: https://www.fiercebiotech.com/person/zoey-becker
See also
FiercePharma is the pharma industry's daily monitor, with a special focus on pharmaceutical company.
Details last updated 14-Feb-2025
The biotech’s advanced AI platform aims to unlock new treatments for challenging drug targets